Moreover, it was observed that high FOXM1 expression in SCLC patients correlated with advanced stage of the disease, extra-thoracic metastases, and poor overall survival (OS) compared to low FOXM1 group [9]. This evidence concerns the gene FOXM1 and small cell lung carcinoma.